Related Experiment Video
Updated: Jan 28, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
EGFR Signaling: Friend or Foe for Cartilage?
Ling Qin1, Frank Beier2,3
1Department of Orthopaedic Surgery Perelman School of Medicine University of Pennsylvania Philadelphia PA USA.
Abstract:
Recent studies using genetically modified mice, pharmacological approaches, and human samples have highlighted an important role for the epidermal growth factor receptor (EGFR), selected ligands, and downstream components in endochondral bone formation and joint homeostasis. Although most data demonstrate an important function of this pathway in endochondral ossification and articular cartilage growth, conflicting results on its role in osteoarthritis have been reported. In some contexts, inactivation of EGFR signaling has been shown to protect joints from surgically induced osteoarthritis, whereas in others, similar manipulations worsened joint pathology. The current review summarizes recent studies of cartilage EGFR signaling in long bone development and diseases, provides potential explanations for the reported discrepancies, and suggests directions for future work to clarify the potential of this pathway as target for osteoarthritis treatment. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
Insights
The epidermal growth factor receptor (EGFR) pathway is crucial for bone development and joint health. However, its role in osteoarthritis is complex, with conflicting evidence on whether EGFR inhibition is protective or detrimental.
Area of Science:
- Skeletal Biology and Disease
- Cell Signaling in Cartilage
Background:
- The epidermal growth factor receptor (EGFR) pathway plays a significant role in endochondral bone formation and maintaining joint homeostasis.
- Recent research using various models has underscored the importance of EGFR, its ligands, and downstream effectors in these processes.
Purpose of the Study:
- To review recent findings on EGFR signaling in cartilage during long bone development and disease.
- To explore conflicting results regarding EGFR's role in osteoarthritis (OA).
- To propose explanations for discrepancies and suggest future research directions for OA therapeutic targeting.
Main Methods:
- Review of recent scientific literature on EGFR signaling in cartilage.
- Analysis of studies involving genetically modified mice, pharmacological interventions, and human samples.
- Synthesis of data from studies on endochondral ossification, cartilage growth, and surgically induced OA models.
Main Results:
- EGFR signaling is vital for endochondral ossification and articular cartilage development.
- Conflicting outcomes exist regarding EGFR's role in osteoarthritis, with some studies showing protection upon inactivation and others demonstrating worsened pathology.
- Discrepancies may arise from differences in experimental models, disease induction methods, and specific pathway components investigated.
Conclusions:
- The precise role of EGFR signaling in osteoarthritis remains unclear due to conflicting experimental evidence.
- Further research is needed to elucidate the complex functions of EGFR in joint pathology.
- Clarifying EGFR's role could identify new therapeutic targets for osteoarthritis treatment.
Related Concept Videos
Growth of Cartilage and Bone Tissue
What is Cell Signaling?
Endocrine Signaling
Paracrine Signaling
Bacterial Signaling
Synaptic Signaling

